Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Monday, June 24, 2024 | Back issues
Courthouse News Service Courthouse News Service

Prescription Drug

NEWARK - GlaxoSmithKline and Teva Pharmaceuticals conspired to restrict competition and raise prices for lamotrigine (Lamictal), a $2 billion-a-year blockbuster drug, a union claims in a federal antitrust class action.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.